| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10308183 | Schizophrenia Research | 2012 | 4 Pages |
Abstract
Metformin was effective and safe in attenuating antipsychotic-induced weight gain and insulin resistance in first-episode schizophrenia patients. Patients displayed good adherence to metformin.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Man Wang, Jian-hua Tong, Gang Zhu, Guang-ming Liang, Hong-fei Yan, Xiu-zhen Wang,